MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Investigating the role of NLRP3 Inflammasome as Biomarkers and Therapeutic Targets in Parkinson’s Disease Pathogenesis

    S. Choudhury, N. Kamble, V. Holla, S. M, P. Pal, R. Yadav, P. Alladi (Bangalore, India)

    Objective: To elucidate the role of NLRP3 Inflammasome in PD pathogenesis and its role in differential susceptibility. Background: Inflammasomes play a role in the progression…
  • 2025 International Congress

    Profile and Predictors of Depression in Parkinson’s Disease Patients attending the Neurology Clinic at the University College Hospital, Ibadan, Nigeria.

    A. Fagbemi, F. Taiwo, T. Sodimu (East Midlands, United Kingdom)

    Objective: My aim is to investigate the frequency, profile, and predictors of depression in PD patients compared to age- and gender-matched controls using the Hamilton…
  • 2025 International Congress

    Developing Disease-duration Specific Percentiles for Prospective Subtyping of the Diffuse Malignant Parkinson’s Disease: A PPMI-based study

    A. Negida, M. Barrett, SM. Fereshtehnejad, B. Berman, N. Mukhopadhyay (Toronto, Canada)

    Objective: To enable prospective identification of individuals with diffuse malignant (DM) Parkinson’s disease (PD) by establishing disease-duration-specific thresholds for motor and non-motor symptom scales. Background:…
  • 2025 International Congress

    A multi-center, randomized, controlled study of the add-on effect of selegiline or zonisamide to L-dopa/DCI therapy in Parkinson’s disease (DATSZ-PD study)

    M. Takahashi, J. Koh, T. Shimokawa, Y. Kajimoto, T. Takeshima, H. Ito (Hirakata, Osaka, Japan)

    Objective: To investigate the efficacy and safety for neuroprotection and disease modifying effect in  selegiline(SL) or zonisamide(ZN) by using UPDRS, PDQ-39 and DAT -SPECT  in…
  • 2025 International Congress

    Rescuing alpha-synuclein toxicity through neuron-specific enhancement of autophagy

    J. Chua, M. Farah, S. Tewari, A. Parvataneni, V. Dawson, T. Dawson (Baltimore, USA)

    Objective: In the present study, we aim to counteract regulatory and transcriptional modifiers of autophagy to enhance neuroprotective proteostasis and rescue alpha-synuclein (asyn) toxicity in…
  • 2025 International Congress

    χ-DBS: An Open-Source Susceptibility Atlas Tool for Deep Brain Stimulation Target Visualization and Segmentation

    A. Roberts, J. Avecillas-Chasin, M. Spadaccia, S. Akkus, A. Dimov, M. Sisman, P. Spincemaille, T. Nguyen, B. Kopell, Y. Wang (Ithaca, USA)

    Objective: This work is motivated by the need for atlas creation tools for susceptibility maps presurgically acquired for deep brain stimulation (DBS). Segmentations aid in…
  • 2025 International Congress

    Modeling Inflammation in GBA-Associated Parkinson’s Disease: Insights into Disease Mechanisms

    V. Lentini, G. Uras, S. Lucas, D. Moreno-Martinez, A. Manca, F. Fierli, S. Koletsi, A. Pantaleo, D. Hughes (Sassari, Italy)

    Objective: This investigation centers on the role of inflammation in GBA-associated Parkinson’s disease (PD), a neurodegenerative disorder characterized by the progressive degeneration of dopaminergic neurons,…
  • 2025 International Congress

    Utilising Beta Power in Local Networks to Predict Freezing of Gait Events in Parkinson’s Disease

    Y. Tian, E. Matar, S. Lewis (Sydney, Australia)

    Objective: Our study examined brain network changes during the transition to Freezing of Gait (FOG) versus voluntary stopping. Identifying specific neural alterations may help establish…
  • 2025 International Congress

    Fatty Acid Metabolic Reprogramming Regulates Glial-Epithelial Axis via Nur77 Palmitoylation in Intestinal Dysfunction in Parkinson’s Disease

    J. Zou, Z. Deng, Z. Lu, X. Luo, F. Yu, W. Bi (Guangzhou, China)

    Objective: This study aims to elucidate the regulatory role of stearoyl-CoA desaturase 1 (SCD1) in Parkinson’s disease (PD)-associated intestinal dysfunction, focusing on its mechanism in…
  • 2025 International Congress

    Metabolomic Profiling in an Egyptian Cohort Reveals Altered Phenylalanine Metabolism and Suggests a Role for Trans-Cinnamate in Parkinson Disease

    N. Shebl, S. El-Jafaary, A. Saeed, P. Elkafrawy, A. El-Sayed, S. Shamma, R. Elmer, J. Mekky, L. Mohamed, O. Kittaneh, H. El-Fawal, M. Rizig, M. Salama (Cairo, Egypt)

    Objective: Investigate the associated metabolic changes in PD via a comprehensive metabolic analysis with a focus on phenylalanine (dopamine precursor) metabolism and its impact on…
  • « Previous Page
  • 1
  • …
  • 171
  • 172
  • 173
  • 174
  • 175
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley